Disability Measures in Stroke: Relationship among the Barthel Index, the Functional Independence Measure, and the Modified Rankin Scale

Stroke

Volumn 35, Issue 4, 2004, Pages 918-923

  Kwon, Sooyeon ^a   Hartzema, Abraham G ^a   Duncan, Pamela W ^b   Lai, Sue Min ^c  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Activities of daily living; Disability evaluation; Outcome assessment; Stroke

Indexed keywords

ADULT; AGED; ARTICLE; BARTHEL INDEX; CLINICAL FEATURE; DAILY LIFE ACTIVITY; DISABILITY; ECONOMIC ASPECT; FEMALE; FUNCTIONAL INDEPENDENCE MEASURE; HUMAN; INTERMETHOD COMPARISON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANKIN SCALE; SCORING SYSTEM; STATISTICAL MODEL; STROKE; UNITED STATES;

ACTIVITIES OF DAILY LIVING; AGED; CEREBROVASCULAR ACCIDENT; DISABILITY EVALUATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 1842523333     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000119385.56094.32     Document Type: Article

References (29)

1. Heart Disease and Stroke Statistics. Dallas, Tex: American Heart Association; 2003.
2. Dobkin B. The economic impact of stroke. Neurology. 1995;45:S6-S9.
3. United States Post-Stroke Rehabilitation Guideline Panel. Post-Stroke Rehabilitation. Washington, DC: GE Gresham and US Agency for Health Care Policy and Research; 1995;18:248. Clinical Practice Guideline No. 16.
4. van der Putten JJ, Hobart JC, Freeman JA, Thompson AJ. Measuring change in disability after inpatient rehabilitation: comparison of the responsiveness of the Barthel index and the functional independence measure. J Neurol Neurosurg Psychiatry. 1999;66:480-484.
5. Kidd D, Stewart G, Baldry J, Johnson J, Rossiter D, Petruckevitch A, Thompson AJ. The functional independence measure: a comparative validity and reliability study. Disabil Rehabil. 1995;17:10-14.
6. Velozo CA, Kielhofner G, Lai JS. The use of Rasch analysis to produce scale-free measurement of functional ability. Am J Occup Ther. 1999;53: 83-90.
7. Chambers MG, Koch P, Hutton J. Development of a decision-analytic model of stroke care in the United States and Europe. Value Health. 2002;5:82-97.
8. Post PN, Kievit J, van Baalen JM, van den Hout WB, van Bockel JH. Routine duplex surveillance does not improve the outcome after carotid endarterectomy: a decision and cost utility analysis. Stroke 2002;33: 749-755.
9. Lai SM, Duncan PW. Evaluation of the American Heart Association stroke outcome classification. Stroke. 1999;30:1840-1843.
10. Lai SM, Duncan PW, Keighley J. Prediction of functional outcome after stroke: comparison of the Orpington Prognostic Scale and the NIH Stroke Scale. Stroke. 1998;29:1838-1842.
11. Duncan PW, Lai SM, Keighley J. Defining post-stroke recovery: implications for design and interpretation of drug trials. Neuropharmacology. 2000;39:835-841.
12. Mahoney FI, Barthel D. Functional evaluation: the Barthel Index. Md Med J. 1965;14:56-61.
13. Granger CV, Hamilton BB, Keith RA, Zielesny M, Sherwin FS. Advances in functional assessment for medical rehabilitation. Top Geriatr Rehabil. 1986;1:59-74.
14. Hamilton BB, Granger CV, Sherwin FS, Zielezny M, Tashman JS. A uniform national data system for medical rehabilitation. In: Fuhrer M, ed. Rehabilitation Outcomes: Analysis and Measurement. Baltimore. Md: Brookes; 1987:137-147.
15. Rankin J. Cerebral vascular accidents in patients over the age of 60. Scott Med J. 1957;2:200-215.
16. Bonita R, Beaglehole R. Recovery of motor function after stroke. Stroke. 1988; 19:1497-1500.
17. Hollander M, Wolfe DA. Nonparametric Statistical Methods. New York, NY: J. Wiley; 1999:240-249.
18. Liao TF. Interpreting Probability Models: Logit, Probit, and Other Generalized Linear Models. Thousand Oaks, Calif: Sage; 1994.
19. Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics. 1998;13:397-409.
20. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making. 1993;13:322-338.
21. Weimar C, Kurth T, Kraywinkel K, Wagner M, Busse O, Haberl RL, Diener HC. Assessment of functioning and disability after ischemic stroke. Stroke. 2002;33:2053-2059.
22. Lai SM, Duncan PW. Stroke recovery profile and the modified Rankin assessment. Neuroepidemiology. 2001;20:26-30.
23. Wallace D, Duncan PW, Lai SM. Comparison of the responsiveness of the Barthel Index and the motor component of the Functional Independence Measure in stroke: the impact of using different methods for measuring responsiveness. J Clin Epidemiol. 2002;55:922-928.
24. Duncan PW. Measuring recovery of function after stroke: clinical and measurement issues in selecting stroke outcome measures in clinical trials. In: Goldstein LB. Restorative Neurology: Advances in Pharmacotherapy for Recovery After Stroke. Armonk, NY: Futura; 1998.
25. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial: Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282: 2003-2011.
26. Trust Study Group. Randomised, double-blind, placebo-controlled trial of nimodipine in acute stroke. Lancet. 1990;336:1205-1209.
27. RANTTAS Investigators. A Randomized Trial of Tirilazad Mesylate in Patients With Acute Stroke (RANTTAS). Stroke. 1996;27:1453-1458.
28. Davis SM, Albers GW, Diener HC, Lees KR, Norris J. Termination of Acute Stroke Studies Involving Selfotel Treatment: ASSIST Steering Committee. Lancet. 1997;349:32.
29. Wahlgren NG, Ranasinha KW, Rosolacci T, Franke CL, van Erven PM, Ashwood T, Claesson L. Clomethiazole Acute Stroke Study (CLASS): results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients. Stroke. 1999;30:21-28.